Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tfh Dysfunction in HIV and Aging
NCT04487041Phase 4Active, not recruiting
- Sponsor
- University of Miami
- Start
- Oct 2020
- Primary completion
- Apr 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of influenza vaccine in Influenza (4 arms), sponsored by University of Miami. Primary endpoints: Change in HAI antibody response at 18 months, Change in neutralization antibody response at 18 months and 1 more. Started Oct 2020; status: active, not recruiting.
02
Drugs
influenza vaccine
03
Conditions
Influenza
Beyond the preview
Go deeper on NCT04487041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487041.